Cite
A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLC.
MLA
Tang, Yijie, et al. “A Cuproptosis Score Model and Prognostic Score Model Can Evaluate Clinical Characteristics and Immune Microenvironment in NSCLC.” Cancer Cell International, vol. 24, no. 1, Feb. 2024, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s12935-024-03267-8.
APA
Tang, Y., Wang, T., Li, Q., & Shi, J. (2024). A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLC. Cancer Cell International, 24(1), 1–16. https://doi.org/10.1186/s12935-024-03267-8
Chicago
Tang, Yijie, Tianyi Wang, Qixuan Li, and Jiahai Shi. 2024. “A Cuproptosis Score Model and Prognostic Score Model Can Evaluate Clinical Characteristics and Immune Microenvironment in NSCLC.” Cancer Cell International 24 (1): 1–16. doi:10.1186/s12935-024-03267-8.